Anbio Biotechnology Income Statement

Income Statement Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 23.54M6.71M8.19M
Cost of Revenue 10.98M3.35M2.30M
Gross Profit 12.56M3.36M5.89M
Operating items
Research & Development 0.20M0.13M0.45M
Selling, General & Administrative 2.17M1.27M3.44M
Operating Expenses 2.37M1.40M3.89M
Operating Income 10.20M1.96M2.00M
EBIT 10.20M1.96M2.00M
Non-operating items
Interest & Investment Income 0.04M0.17M0.34M
Other Non Operating Income -0.26M0.12M0.02M
Non Operating Income -0.18M0.29M0.38M
Net income details
EBT 10.01M2.25M2.37M
Profit After Tax 10.01M2.25M2.37M
Income from Continuing Operations 10.01M2.25M2.37M
Consolidated Net Income 10.01M2.25M2.37M
Income towards Parent Company 10.01M2.25M2.37M
Net Income towards Common Stockholders 10.01M2.25M2.37M
Additional items
EPS (Basic) 0.10M0.110.06
EPS (Weighted Average and Diluted) 0.10M0.110.06
Shares Outstanding (Weighted Average) 142.29M142.29M
EBITDA 10.20M1.96M2.00M
Interest Expenses 0.01M